The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...
ATLANTA — The Federal Trade Commission on Wednesday announced it is sending more than $47 million in checks to renters who were deceived by Invitation Homes, one of the largest landlords in the ...
There's new evidence that GLP-1 drugs like Ozempic can reduce the risk of addiction. A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 ...
What began as an unexpected observation and “side effect” of some medications converged with decades of addiction neuroscience: GLP-1 receptor agonist medications like Ozempic apparently reduce ...
Finally you can invest like the 1% - use this stress test before getting locked into private markets
Private credit and other institutional investments are now within reach for individuals. But their promises don't always align with your portfolio. Buying into a private-market fund isn't like buying ...
FTC says it won’t enforce COPPA against proper use of age verification tools The Federal Trade Commission (FTC) on Wednesday issued a policy statement advising industry that it will not bring ...
Share on Pinterest Reports of people developing scurvy while taking GLP-1 medications are on the rise. Milles Team/Shutterstock Reports of GLP-1 users developing scurvy have increased in recent months ...
Dushay is an assistant professor of medicine at Harvard Medical School and an attending endocrinologist at Beth Israel Deaconess Medical Center. It makes my head spin to think about how much GLP-1s ...
We are making a handful of trades on Wednesday. We're buying 30 shares of Capital One Financial at roughly $208 each, increasing the weighting in Jim Cramer's Charitable Trust to 3.05% from 2.9% and ...
The US Federal Trade Commission is accelerating scrutiny of Microsoft Corp. as part of an ongoing probe into whether the company illegally monopolizes the enterprise computing market with its cloud ...
With off‑label use surging, it’s virtually impossible to know how many people are currently taking GLP‑1 drugs like Wegovy or Mounjaro, or how many will be prescribed them in the years ahead. The same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results